A multicenter randomized controlled trial to test the effects of an ICT- guided-DMS combined with telemonitoring in HF-patients (IN TOUCH trial).

The intervention did not affect the primary endpoint of mortality, HF- readmissions and quality of life.

Use of telemonitoring is safe and can reduce HF-related visits to the HF outpatient clinic keeping HF-care accessible.

The adherence of patients using telemonitoring was very high indicating that the devices used in combination with daily measurements were well accepted by patients.